Literature DB >> 7650015

Characterization of an enhancer element in the human apolipoprotein C-III gene that regulates human apolipoprotein A-I gene expression in the intestinal epithelium.

J G Bisaha1, T C Simon, J I Gordon, J L Breslow.   

Abstract

Studies using transgenic mice indicate that expression of the human apolipoprotein (apo) A-I gene in the liver and small intestine is controlled by spatially distinct cis-acting DNA elements; hepatic expression is controlled by a domain defined by nucleotides -256 to -1, while small intestinal expression requires elements positioned 9 kilobases 3' to the gene, between nucleotides -1300 and -200 of the convergently transcribed apoC-III gene. In this report we have mapped this enhancer to a 260-base pair (bp) region of the apoC-III promoter spanning nucleotides -780 to -520. The elements contained within this 260-bp apoC-III domain are sufficient to direct a pattern of expression in villus-associated enterocytes distributed along the duodenal-to-ileal axis that resembles that of mouse and human apoA-I. However, the elements produce inappropriate activation of apoA-I expression in proliferating and nonproliferating crypt epithelial cells, and in subpopulations of cholecystokinin- and serotonin-producing enteroendocrine cells. Cis-acting suppressors of these inappropriate patterns of expression are located outside of nucleotides -1300 to -200 of the human apoC-III gene. DNase I protection and gel mobility gel shift assays identified two 21-bp sequences, nucleotides -745 to -725 and -700 to -680 of human apoC-III, which bind nuclear proteins present in a human enterocyte-like cell line (Caco-2). These sequences are conserved in the orthologous mouse apoC-III gene. The 260-bp apoC-III element is the first intestinal enhancer that has been identified in an in vivo system and should provide insights about how cell lineage-specific, differentiation-dependent, and cephalocaudal patterns of gene expression are established and maintained in the perpetually renewing gut epithelium. In addition, novel intestinal transcription factors may bind to the enhancer and regulate its activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7650015     DOI: 10.1074/jbc.270.34.19979

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues.

Authors:  H Ye; T F Kelly; U Samadani; L Lim; S Rubio; D G Overdier; K A Roebuck; R H Costa
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

2.  DNA binding and transcription activation specificity of hepatocyte nuclear factor 4.

Authors:  J D Fraser; V Martinez; R Straney; M R Briggs
Journal:  Nucleic Acids Res       Date:  1998-06-01       Impact factor: 16.971

3.  Identification and characterization of the MUC2 (human intestinal mucin) gene 5'-flanking region: promoter activity in cultured cells.

Authors:  J R Gum; J W Hicks; Y S Kim
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

4.  Activation of enhancer elements by the homeobox gene Cdx2 is cell line specific.

Authors:  J K Taylor; T Levy; E R Suh; P G Traber
Journal:  Nucleic Acids Res       Date:  1997-06-15       Impact factor: 16.971

5.  Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV.

Authors:  R D Cohen; L W Castellani; J H Qiao; B J Van Lenten; A J Lusis; K Reue
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

6.  Intestinal transcription and synthesis of apolipoprotein AI is regulated by five natural polymorphisms upstream of the apolipoprotein CIII gene.

Authors:  S Naganawa; H N Ginsberg; R M Glickman; G S Ginsburg
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

7.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.

Authors:  S Gupta; A M Pablo; X c Jiang; N Wang; A R Tall; C Schindler
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

8.  Regulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acid.

Authors:  Carlos Hernandez; Matthew Molusky; Yaqiang Li; Siming Li; Jiandie D Lin
Journal:  Cell Metab       Date:  2010-10-06       Impact factor: 27.287

Review 9.  High density lipoprotein, apolipoprotein A-I, and coronary artery disease.

Authors:  R A Srivastava; N Srivastava
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

10.  The SP1 sites of the human apoCIII enhancer are essential for the expression of the apoCIII gene and contribute to the hepatic and intestinal expression of the apoA-I gene in transgenic mice.

Authors:  S Georgopoulos; H Y Kan; C Reardon-Alulis; V Zannis
Journal:  Nucleic Acids Res       Date:  2000-12-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.